A Randomized, Double-blind, Placebo-controlled Phase Ib Clinical Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Continuous Intravenous Infusion of STC314 Injection in Chinese Patients With Acute Respiratory Distress Syndrome
Latest Information Update: 07 Dec 2023
At a glance
- Drugs STC 314 (Primary)
- Indications Adult respiratory distress syndrome
- Focus Adverse reactions; Pharmacokinetics
- 23 Dec 2021 Status changed from not yet recruiting to recruiting.
- 06 Sep 2021 Planned initiation date changed from 1 Aug 2021 to 1 Sep 2021.
- 19 Aug 2021 New trial record